Literature DB >> 12788374

Serum response factor: toggling between disparate programs of gene expression.

Joseph M Miano1.   

Abstract

Serum response factor (SRF) is a widely expressed transcription factor involved in orchestrating disparate programs of gene expression linked to muscle differentiation and cellular growth. Vascular smooth muscle cell (SMC) differentiation, for example, is marked by the coordinate expression of several contractile and cytoskeletal genes regulated directly by SRF through one or more CArG-box elements in the immediate vicinity of transcription start sites. In vascular disease, this CArG-dependent program of SMC differentiation is compromised and numerous CArG-dependent early growth-response genes are activated. Thus, SRF must toggle between programs of SMC differentiation and growth depending on local environmental cues. Moreover, SRF must distinguish between a course of SMC differentiation and programs of cardiac and skeletal muscle differentiation. Several mechanisms exist to ensure context- and cell-specific programs of SRF-dependent gene expression. These include regulated expression, DNA binding, and alternative splicing of SRF, flanking sequences adjacent to and chromatin remodeling of CArG boxes, RhoA-mediated alterations in the cytoskeleton, and association of SRF with a variety of cell-restricted cofactors including the recently discovered myocardin coactivator. Although many SMC-differentiation genes require critical evolutionarily conserved CArG boxes for SMC-restricted promoter activity in cultured cells and transgenic mice, the expression of a growing number of similarly restricted genes appears to be independent of SRF. Thus, parallel circuits of gene transcription have evolved for the appropriate expression of all genes that define mammalian SMC lineages. The purpose of this review is to summarize the history and progress made in SRF research with emphasis on the role this transcription factor plays in facilitating a program of SMC-restricted gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788374     DOI: 10.1016/s0022-2828(03)00110-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  240 in total

1.  Characterization of Pax3-expressing cells from adult blood vessels.

Authors:  Olivier Goupille; Giorgia Pallafacchina; Frédéric Relaix; Simon J Conway; Ana Cumano; Benoit Robert; Didier Montarras; Margaret Buckingham
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

2.  A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.

Authors:  Christina Pagiatakis; Joseph W Gordon; Saviz Ehyai; John C McDermott
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

3.  Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.

Authors:  Jee In Kim; Mark Urban; Garbo D Young; Masumi Eto
Journal:  Am J Physiol Cell Physiol       Date:  2012-04-25       Impact factor: 4.249

4.  cGMP-dependent protein kinase and the regulation of vascular smooth muscle cell gene expression: possible involvement of Elk-1 sumoylation.

Authors:  ChungSik Choi; Hassan Sellak; Felricia M Brown; Thomas M Lincoln
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-27       Impact factor: 4.733

5.  MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function.

Authors:  Sebastian Albinsson; Yajaira Suarez; Athanasia Skoura; Stefan Offermanns; Joseph M Miano; William C Sessa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-08       Impact factor: 8.311

Review 6.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

7.  Dicing up microRNA gene expression profiles in normal and neoplastic smooth muscle cells.

Authors:  Joseph M Miano
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

8.  NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

Authors:  Abel Martin-Garrido; David I Brown; Alicia N Lyle; Anna Dikalova; Bonnie Seidel-Rogol; Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

9.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

10.  LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation.

Authors:  Norihiko Sakai; Jerold Chun; Jeremy S Duffield; Takashi Wada; Andrew D Luster; Andrew M Tager
Journal:  FASEB J       Date:  2013-01-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.